Quadessy delivers multi-layer skin remodeling through a unique tip and dual-depth design
A Digital Publication for the Practicing Medical Specialist, Industry Executive and Investor
Medical Device News Magazine is committed to delivering high‑quality, in‑depth medical device news and biotechnology updates that include expert bylines. Our coverage offers a comprehensive view of the trends, innovations, and breakthroughs shaping the future of medical technology.
We also strive to provide a distinctive perspective on the rapidly evolving healthcare landscape. By staying connected with our reporting, you gain access to exclusive insights on industry developments, emerging technologies, and global regulatory changes that influence the medical device sector. At the same time, you join a vibrant community of professionals, innovators, and thought leaders dedicated to advancing healthcare through cutting‑edge solutions.
We invite you to explore our wide range of content—from the latest product announcements to detailed analyses of industry trends. And if our mission aligns with your goals, we offer opportunities for advertising and collaboration, helping you connect with a highly engaged audience of medical technology professionals.
Definition medical devices.
Quadessy delivers multi-layer skin remodeling through a unique tip and dual-depth design
Medtronic's latest partnership with Merit Medical Systems introduces the groundbreaking ViaVerte™ BVNA system—an innovative solution for chronic vertebrogenic pain
Led by researchers at the Vanderbilt University Medical Center, a new study reports that Optellum's FDA-cleared Lung Cancer Prediction (LCP) AI assisted risk stratification for indeterminate lung nodules is cost-effective from a US payer perspective. Optellum's LCP AI supports more consistent long nodule management and helps enable earlier diagnosis of...
First patient dosed in Opti-GAIN, a first-in-human Phase I/II clinical trial of CTx001 in Geographic Atrophy secondary to AMD
The study, published in The March 2026 edition of Federal Practitioner, reported an association between thermal therapy use and reduced opioid and benzodiazepine utilization, as well as lower healthcare utilization in the patient population.
The Journal of the American Medical Association (JAMA Neurology) publication highlights consistent clinical and biomarker findings from NeuroSense PARADIGM Phase 2b trial in ALS, including slower functional decline, reduced risk of ALS-related complications, and modulation of disease-relevant biomarkers
Joint initiative with Rosebud Biosciences, Kantify, and funded by Incite will identify and quantify off-target toxicities in chemotherapy patients
Robust DNA extraction supports earlier detection and diagnosis of colorectal cancer and other gastrointestinal diseases
Redipor® Legionella agar plate range - specifically designed to support the detection and enumeration of Legionella in water samples
To enhance physician visualization during surgical oncology procedures. New funding to support building image-guided surgical navigation platform.

This funding will support the development of Avian H5 Influenza detection capabilities on the Metrix® platform, expanding upon its recent U.S. Food and Drug Administration (FDA) emergency use authorized COVID-19/Flu multiplex test.

The integration of hybrid AI into the drug development process represents a transformative shift that will not only accelerate the discovery of new therapies but also enhance their precision and safety.

Organizations must adopt a proactive defense strategy to stay ahead, which isn’t always easy to do with human capabilities that are limited. Fortunately, artificial intelligence can act as an auxiliary defense force and play a key role in helping improve cybersecurity efforts in a number of ways, responding faster than human teams alone.

Chuck Papageorgiou writes: “With no effective prevention or long-term treatment, receiving a diagnosis of Alzheimer’s disease can seem like a fate worse than death for patients and their families and caregivers. However, a wave of innovation is bringing new hope to the 7 million Americans already living with Alzheimer’s disease and the 500,000 who will receive this devastating diagnosis each year.”
The ADAPT study will evaluate the safety and effectiveness of the company’s Calibreye™ Titratable Glaucoma Therapy™ (TGT) Surgical System
This expansion of indications now includes use as a bone void filler for the treatment of tumors, cysts, trauma, and osteomyelitis. This landmark clearance represents a significant advancement in the capabilities of SurGenTec®’s cutting-edge technology and highlights the company’s commitment to enhancing patient care in orthopedic and spine surgery.
“Not only are these individuals expert in their respective fields, they are also highly collaborative, fantastic leaders, and embody the mission and culture of the company” said Alison Burklund, Ph.D., Co-Founder and Co-CEO at Nanopath
Dr. Di Marco brings over 25 years of experience in the biopharmaceutical industry through multiple executive leadership positions
In his role, Danny Marshall will focus on scaling patient-first product innovation and Inventus’ global platform
SubtleHD sets a new benchmark in image quality and speed for European MRI providers.
This partnership immediately positions NeuralCure AI for rapid, real-world application, further solidifying its role as a pioneer in AI-powered healthcare solutions. Unlike traditional AI models that provide generalized insights, NeuralCure AI creates patient-specific digital twins and runs constant treatment simulations, helping physicians make more informed, data-driven decisions without replacing clinical judgment.

Discover how Philips and Mass General Brigham are transforming healthcare with innovative AI solutions for better patient outcomes.
Pam Health advises the new hospital will create approximately 80 new jobs including medical professional and support staff positions.

People living with tricuspid valve disease are gaining more treatment options, driven by research from Cedars-Sinai investigators and collaborators at other leading medical institutions.

Marcus Neuroscience Institute, part of Baptist Health, at Bethesda Hospital West, is the first hospital in the state of Florida to perform and offer next-generation augmented reality spinal surgery with novel, advanced, high-resolution AR technology. The surgery was done by neurosurgeon Timothy O’Connor, M.D., director of minimally invasive and robotic spine surgery. Marcus Neuroscience Institute is one of the first medical centers in the world to use this next-generation augmented reality technology.

AI medical scribes play a crucial role for clinicians and patients. Traditional scribes create documentation and burnout crises, security and privacy issues, and poor communication between physicians and patients, while AI ambient scribes can effectively address documentation crises, reduce burnout, enhance patient experience and well-being, and offer cost-effective and scalable solutions

Advertising has come a long way since paper-painted signs were posted on the side of the road. Now, digital billboards convey your brand narrative more effectively than

Learn how Bleach-Infiniter helps Chicago clinics enhance services without added expenses, boosting competitiveness in healthcare

Maintaining compliance is one of the most important responsibilities healthcare facilities face—and one of the most complex
Medical Device News Magazine uses cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Google Tag Manager simplifies the management of marketing tags on your website without code changes.
You can find more information in our Cookie Policy: Medical Device NewsMagazine and PRIVACY.